Cargando…
ATG/ALG联合环孢素A治疗老年重型再生障碍性贫血16例疗效及安全性评估
OBJECTIVE: To evaluate the efficacy and safety of intensive immunosupressive therapy (IST) with antithymocyte/antilymphocyte globulin plus cyclosporine A in the treatment of older patients (≥60 years) with severe aplastic anemia (SAA). METHODS: The hematologic response and safety of sixteen older SA...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Editorial office of Chinese Journal of Hematology
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7365008/ https://www.ncbi.nlm.nih.gov/pubmed/27535863 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2016.07.013 |
Ejemplares similares
-
艾曲波帕联合环孢素A治疗极重型再生障碍性贫血一例
Publicado: (2019) -
ATG/ALG联合环孢素A与环孢素A联合雄激素一线治疗输血依赖非重型再生障碍性贫血的疗效比较:单中心回顾性研究
Publicado: (2016) -
环孢素A联合雄激素治疗输血依赖非重型再生障碍性贫血预后因素分析
Publicado: (2020) -
52例非重型再生障碍性贫血患者环孢素A治疗前后生活质量的变化研究
Publicado: (2020) -
重组人红细胞生成素联合环孢素A治疗获得性纯红细胞再生障碍的疗效与安全性
Publicado: (2021)